MRVL — Marvel Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for Marvel Biosciences, fiscal year end - July 31st, CAD millions except per share, conversion factor applied.

	2021 July 31st	2022 July 31st	2023 July 31st	2024 July 31st	2025 July 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	2.39	0.593	0.557	0.346	0.129
Net Total Receivables	0.059	0.056	0.082	0.116	0.168
Prepaid Expenses
Total Current Assets	2.47	0.914	0.672	0.491	0.327
Net Property, Plant And Equipment	0	0	—	—	—
Total Assets	2.47	0.914	0.672	0.491	0.327
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.112	0.718	1.39	1.61	4.33
Long Term Debt
Total Long Term Debt
Total Debt
Total Liabilities	0.112	0.718	2.39	3.32	4.33
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	2.36	0.196	-1.72	-2.83	-4.01
Total Liabilities & Shareholders' Equity	2.47	0.914	0.672	0.491	0.327
Total Common Shares Outstanding